← FDA DRUG APPROVALS

FDA NDA · NDA050571

CEFMAX

Sponsor: TAP PHARM

APPLICATION
NDA050571
TYPE
NDA
ORIGINAL APPROVAL
1987-12-30
LATEST ACTION
1988-05-06
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CEFMAXDiscontinued
CEFMENOXIME HYDROCHLORIDE EQ 2GM BASE/VIAL · INJECTABLE · INJECTION
CEFMAXDiscontinued
CEFMENOXIME HYDROCHLORIDE EQ 500MG BASE/VIAL · INJECTABLE · INJECTION
CEFMAXDiscontinued
CEFMENOXIME HYDROCHLORIDE EQ 1GM BASE/VIAL · INJECTABLE · INJECTION

Approval history

1988-05-06Labeling · Supplement 1 · standardAP
1987-12-30Type 1 - New Molecular Entity · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →